ArticleJournal of translational medicine2025

Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer.

XinJian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.